VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RVTY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RVTYRevvity, Inc.
$111.21$12.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRVTYCash Flow

Revvity, Inc. (RVTY) Cash Flow Statement

30Y historyFree accessUpdated daily

Cash conversion remains robust with an OCF/NI ratio of 2.83 in 2026Q1, though management has prioritized aggressive capital deployment through $293.9 million in quarterly buybacks as recently as 2025Q2.

RVTY Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations571.23M581.78M628.3M91.27M679.81M1.41B892.18M363.47M311.04M288.45M350.62M287.1M281.6M158.59M152.17M224.87M164.25M148.72M217.84M205.13M127.44M208.09M200.76M167.47M101.5M123.3M145.55M115.8M69.6M34.8M80.2M
Operating CF Margin %-20.37%22.81%3.32%20.53%36.86%23.59%12.6%11.2%12.78%16.57%13.64%12.59%7.32%7.19%11.7%9.64%9.59%11.11%11.48%8.24%14.12%14.05%10.91%6.74%9.27%8.59%8.5%4.94%2.38%5.62%
Operating CF Growth %-26.64%-7.4%588.38%-86.57%-51.81%58.12%145.46%16.86%7.83%-17.73%22.12%1.95%77.56%4.22%-32.33%36.91%10.44%-31.73%6.2%60.96%-38.76%3.65%19.87%64.99%-17.68%-15.29%25.69%66.38%100%-56.61%-46.6%
Net Income240.96M241.2M283.07M179.5M512.68M889.44M630.56M227.75M237.47M156.89M215.71M188.78M130.14M174.27M71.29M1.17M138.91M74.33M127.77M131.69M119.58M66.53M75.88M52.96M-151.94M34.51M90.52M154.3M102M33.7M60.2M
Depreciation & Amortization412.97M405.34M427.85M431.77M427M311.44M201.65M214.03M180.59M105M99.97M105.36M110.47M126.88M125.13M110.92M89.16M80.76M88.61M80.83M69.48M124.38M75.7M89.78M96.11M84.26M87.72M66.1M48.5M42.7M40.9M
Stock-Based Compensation23.83M22.85M37.81M41.41M51.52M29.68M26.9M31.51M28.77M25.42M17.16M17.28M14.06M14.05M20.63M15.48M12.42M13.99M19.34M000000000000
Deferred Taxes-61.48M-61.48M-110.31M-97.48M-107.41M-53.4M-30.82M-61.78M-51.77M29.04M-6.82M-11.91M-40.96M-64.36M-64.17M5.19M-32.17M27.5M-12.07M-21.82M-10.01M1.42M21.93M-11.84M-35.37M00011.3M00
Other Non-Cash Items58.16M70.65M8.18M-72.58M58.99M100.61M215.21M116.61M46.71M9.77M59.63M52.53M128.17M22.36M143.22M82.84M-4.08M43.12M4.02M5.92M9.79M11.43M28.87M14.17M143.59M39.46M-5.78M-87.4M-114.4M15.8M-400K
Working Capital Changes-103.2M-96.78M-18.3M-391.35M-262.97M132.99M-151.32M-164.66M-130.73M-37.66M-35.03M-64.94M-60.28M-114.6M-143.92M9.27M-39.99M-90.98M-9.83M8.51M-61.4M4.33M-1.63M22.4M49.11M-34.93M-26.91M-17.2M22.2M-57.4M-20.5M
Change in Receivables-57.62M-101.02M-15.97M-9M66.09M165.59M-398.85M-100.63M-94.51M-36.63M-18.96M4.06M-12.06M-14.07M-44.88M-20.6M-38.1M-30.44M-11.69M-29.65M3.31M-10.43M17.95M43.36M35.28M13.97M-4.26M-54.4M7.8M-24.5M-11.8M
Change in Inventory7.43M14.78M45.09M-14.11M-48.63M32.28M-127.36M-9.61M-30.18M-17.92M6.75M-27.93M-19.44M-14.17M-7.86M-2.2M-22.54M-4.47M-10.17M341K-11.07M-323K5.63M28.16M48.23M-39.5M-23.38M12.1M3.3M-2.5M-6.7M
Change in Payables-15.25M7.34M-26.02M-76.43M-43.8M-7.58M63.23M7.35M8.9M34.33M30.72M-10.9M2.85M-1.08M-8.08M-1.78M27.79M-10.44M4.82M000000000000
Cash from Investing-89.25M-17.35M776.16M1.31B-132.85M-4.11B-504.5M-487.57M-159.86M-1.27B-83.88M-100.86M-295.9M-1.21M-80.31M-909.86M295.15M-153.87M-135.68M-349.34M-139.5M323.29M-11.68M177.23M-156.04M66.52M-401.43M-143.9M-46.5M1.9M-71.3M
Capital Expenditures-77.31M-73.52M-86.65M-81.37M-85.63M-86.02M-63.63M-81.33M-93.25M-39.09M-31.7M-28.22M-27.15M-38.98M-42.4M-30.59M-33.65M-25.52M-43.33M-46.98M-44.47M-25.05M-15.82M-17.55M-67.82M-88.7M-70.6M-343.4M-262.4M-51.3M-80.5M
CapEx % of Revenue2.66%2.57%3.15%2.96%2.59%2.25%1.68%2.82%3.36%1.73%1.5%1.34%1.21%1.8%2%1.59%1.97%1.65%2.21%2.63%2.88%1.7%1.11%1.14%4.51%6.67%4.16%25.19%18.64%3.51%5.64%
Acquisitions-67.28M00-1.93M6.99M-3.98B-407.21M-399.86M-59.66M-1.53B-50.92M-72.04M-271.48M-15.7M-40.86M-914.04M-150.37M-101.93M-90.66M-315.87M-133.13M-17.57M2.77M534K-22.51M45.46M-397.38M0000
Investments-------------------------------
Other Investing56.11M56.55M156.9M2.07B-15.91M-22.96M-13.59M072K272.82M-1.26M-598K2.73M53.47M2.95M34.77M479.17M-26.43M-1.7M13.51M14.48M365.91M1.37M194.24M-65.71M109.76M87.01M193.4M208.3M49.1M-200K
Cash from Financing-782.75M-855.05M-1.13B-947.12M-661.8M2.94B-202.87M150.13M-179.23M782.24M-115.01M-107.14M30.93M-154.16M-44.16M397.2M-218.37M2.41M-101.08M148.89M-313.51M-217.85M-195.94M-298.35M30.67M-170.33M259.79M62M14M-22.7M-36.5M
Debt Issued (Net)-471K-521K-723.07M-517.49M-559.17M3.04B-187.47M208.87M-66.04M822.16M63.09M-35.07M106.33M-16.84M-35.58M518.56M-141M44.83M-9.52M359.03M-110.75M-166.7M-174.96M-262.17M68.67M-177M251.01M59.5M52.4M24.5M16M
Equity Issued (Net)-747.98M-817.89M-369.58M-388.88M-66.52M-47.95M30.73M-6.31M-57.45M-3.83M-151.8M-76.44M-65.53M-127.4M-2.1M-110M-72.77M-8.38M-31.77M-170.59M-168.6M-5.01M15.04M3.62M13.13M37.69M36.31M27.9M-12.9M-21.4M-26M
Dividends Paid-32.21M-32.8M-34.45M-34.97M-35.34M-32.37M-31.21M-31.06M-31.01M-30.79M-30.8M-31.57M-31.62M-31.6M-31.9M-31.83M-32.99M-32.7M-33.07M-33.7M-35.45M-36.3M-35.78M-35.41M-35.28M-28.29M-27.53M-25.5M-25.4M-25.7M-26.6M
Share Repurchases-753.72M-820.82M-369.58M-388.88M-80.64M-73.07M-6.94M-6.31M-57.45M-3.83M-151.8M-76.44M-65.53M-127.4M-2.1M-110M-72.77M-14.62M-75.51M-202.97M-190.12M-24.4M00-5.92M-1.78M-10.59M-1M-41.2M-28.1M-30.8M
Other Financing-2.09M-3.84M-1.13M-5.79M-767K-21M-14.92M-21.37M-24.73M-5.29M4.5M35.94M21.75M21.68M25.42M20.48M28.39M-1.34M-26.72M-5.85M1.3M-9.85M-237K-4.38M-15.84M-2.73M0100K-100K-100K100K
Net Change in Cash-277.94M-244.59M250.08M443.63M-148.59M216.72M210.72M25.58M-36.05M-157.13M121.33M63.11M1.58M1.8M29.1M-277.74M240.38M597K-24.24M12.29M-311.2M304.75M6.01M60.88M-7.63M13.97M-1.1M31.1M37.6M10M-28.3M
Free Cash Flow504.75M508.25M541.65M9.9M594.18M1.32B828.54M282.14M217.78M249.36M318.91M257.47M252.53M119.6M109.76M194.28M130.61M117.04M174.52M158.15M82.97M183.04M181.8M149.93M33.69M34.6M74.95M-227.6M-194.9M-13.9M-300K
FCF Margin %17.39%17.8%19.66%0.36%17.94%34.61%21.9%9.78%7.84%11.05%15.07%12.23%11.29%5.52%5.19%10.11%7.66%7.55%8.9%8.85%5.37%12.42%12.72%9.77%2.24%2.6%4.42%-16.7%-13.84%-0.95%-0.02%
FCF Growth %-3.69%-6.17%5369.01%-98.33%-55.15%59.89%193.67%29.55%-12.66%-21.81%23.87%1.96%111.14%8.96%-43.5%48.75%11.6%-32.94%10.35%90.62%-54.67%0.69%21.26%345.09%-2.64%-53.84%132.93%-16.78%-1302.16%-4533.33%-100.34%
FCF per Share4.514.494.410.084.7011.357.392.531.952.252.892.272.221.050.961.711.111.001.471.310.661.391.401.160.270.320.74-2.49-2.12-0.15-0.00
FCF Conversion (FCF/Net Income)2.09x2.41x2.12x-0.77x1.19x1.50x1.23x1.60x1.30x2.55x1.50x1.35x1.78x0.94x2.22x191.87x0.43x1.74x1.70x1.54x1.09x2.55x2.65x3.16x-24.55x-198.87x1.61x4.08x0.68x1.03x1.33x
Interest Paid0091.09M94.01M97.93M54.12M42.14M82.69M56.45M35.78M30.72M31.74M30.32M39.9M40.45M12.18M12.23M12.41M20.16M000000000000
Taxes Paid00154.88M359.8M323.08M364.56M162.45M77.06M59.84M77.61M43.55M49.27M40.64M36.67M53.28M41.64M32.91M35.38M38.36M000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Newborn screening volume sensitivity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Masked by Accruals

As reported in recent financial filings, Revvity consistently generates operating cash flow significantly higher than net income, with the OCF/NI ratio reaching 2.83 in 2026Q1, suggesting that non-cash charges and accounting adjustments play a disproportionate role in the company's reported bottom-line profitability metrics.

The persistent gap between net income and operating cash flow indicates that reported earnings are heavily influenced by substantial depreciation and amortization expenses, likely tied to the integration of recent acquisitions. Investors should monitor whether this divergence reflects genuine operational efficiency or simply the accounting treatment of intangible assets following the company's portfolio transformation.

FCF Margins Reflect Operational Transition

Based on the provided cash flow data, Revvity's free cash flow margin has fluctuated between 14.9% and 24.8% over the last ten quarters, indicating that while the company remains cash-generative, its ability to convert revenue into free cash flow remains sensitive to ongoing restructuring and integration costs.

The variability in FCF margins suggests that the company's cash generation profile is still stabilizing post-divestiture. While the business maintains a consistent ability to produce cash, the lack of a clear upward trajectory in FCF margins warrants further investigation into whether current cost structures are fully optimized for the new pure-play model.

Capital Intensity Remains Structurally Low

According to historical cash flow statements, Revvity maintains a disciplined capital expenditure profile, with CapEx/Revenue ratios consistently hovering between 2.4% and 3.5%, suggesting that the company's core diagnostic and life science operations do not require heavy, recurring reinvestment to maintain their current installed base.

This low capital intensity is a positive indicator for long-term cash flow sustainability, as it allows a greater portion of operating cash flow to be directed toward debt reduction or shareholder returns. The stability of these expenditures implies that the company's primary growth drivers are likely driven by reagent pull-through and software rather than massive infrastructure expansion.

Working Capital Volatility Impacts Liquidity

Data from recent quarterly reports reveals significant swings in working capital, ranging from a $82.8 million inflow in 2023Q4 to a $48.9 million outflow in 2025Q2, highlighting the inherent difficulty in managing inventory and receivables during the company's ongoing organizational and portfolio realignment.

These fluctuations suggest that Revvity's cash conversion cycle is susceptible to timing differences in product shipments and collections, which may be exacerbated by the transition to new business segments. Investors should monitor these working capital movements closely, as they represent a primary source of quarterly cash flow volatility that can obscure underlying operational performance.

Aggressive Capital Allocation Prioritizes Buybacks

As evidenced by the cash flow statements, Revvity has prioritized share repurchases over other forms of capital deployment, with quarterly buybacks reaching as high as $293.9 million in 2025Q2, signaling a management focus on returning capital to shareholders despite the ongoing costs of portfolio integration.

The scale of these repurchases relative to free cash flow suggests a high degree of confidence in the company's long-term valuation, though it also limits the cash available for organic R&D or strategic bolt-on acquisitions. This capital allocation strategy warrants further investigation to ensure that the company is not sacrificing necessary growth investments for short-term earnings per share support.

RVTY — Frequently Asked Questions

Quick answers to the most common questions about buying RVTY stock.

How much cash does Revvity, Inc. (RVTY) generate from operations?

Revvity, Inc. (RVTY) generated $581.8M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Revvity, Inc.'s free cash flow?

Revvity, Inc. (RVTY) generated $508.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Revvity, Inc.'s capital expenditure (CapEx)?

Revvity, Inc. (RVTY) spent $73.5M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Revvity, Inc. distribute cash to shareholders?

In 2025, Revvity, Inc. (RVTY) returned $32.8M to shareholders via cash dividends and spent $820.8M on share repurchases. This shows the company's commitment to returning capital to its equity investors.